文献速递糖尿病肥胖与代谢综合征

老龄化糖尿病:构建临床指导证据基础的路径

Diabetes in ageing: pathways for developing the evidence base for clinical guidance.
PubMed 文献 · Lancet Diabetes Endocrinol · 2020-01-01

老年糖尿病患者在医学、功能和认知状态上异质性强,需个体化治疗方案。本综述由多学科专家团队描述老年糖尿病若干重要领域的当前证据,并列出各领域关键研究空白和研究问题,以期为改善老年患者结局制定循证推荐。

要点

  • 老年糖尿病患者异质性强,需按年龄、功能、衰弱和合并症个体化治疗。
  • 现有临床试验证据不足,老年糖尿病临床指导有限。
  • 综述梳理关键领域证据空白,提出研究问题以支持循证推荐。

核心结论

  • 老年糖尿病证据基础不足,需针对不同特征人群开展研究以制定循证临床指导。

研究设计与样本

  • 本综述由多学科专家团队撰写,描述老年糖尿病若干重要领域的当前证据并列出研究空白。

主要发现

  • 老年糖尿病患者在医学、功能和认知状态上异质,需个体化治疗。
  • 缺乏涉及不同特征老年人群的临床试验详细信息,循证指导有限。
  • 老年糖尿病患者按年龄、功能健康、衰弱和合并症特征存在差异。

临床怎么用

  • 对所有老年糖尿病患者采取个体化照护,从健壮个体到养老院居住、预期寿命短、需姑息或临终管理的患者。

局限性

  • 缺乏涉及不同特征老年人群的临床试验详细信息,证据基础有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Older adults with diabetes are heterogeneous in their medical, functional, and cognitive status, and require careful individualisation of their treatment regimens. However, in the absence of detailed information from clinical trials involving older people with varying characteristics, there is little evidence-based guidance, which is a notable limitation of current approaches to care. It is important to recognise that older people with diabetes might vary in their profiles according to age category, functional health, presence of frailty, and comorbidity profiles. In addition, all older adults with diabetes require an individualised approach to care, ranging from robust individuals to those residing in care homes with a short life expectancy, those requiring palliative care, or those requiring end-of-life management. In this Review, our multidisciplinary team of experts describes the current evidence in several important areas in geriatric diabetes, and outlines key research gaps and research questions in each of these areas with the aim to develop evidence-based recommendations to improve the outcomes of interest in older adults.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Munshi MN, Meneilly GS, Rodríguez-Mañas L, et al. Diabetes in ageing: pathways for developing the evidence base for clinical guidance. Lancet Diabetes Endocrinol. 2020. PMID: 32946822. doi:10.1016/S2213-8587(20)30230-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。